Induction of Demyelination by a Temperature-sensitive Mutant of the Coronavirus MHV-A59 is Associated with Restriction of Viral Replication in the Brain Free

Abstract

SUMMARY

The neurovirulence of eight temperature-sensitive () mutants of mouse hepatitis virus strain A59 in 4-week-old BALB/c mice was investigated. Whereas a dose of 100 p.f.u. of wild-type virus killed mice within a week, a 1000-fold higher dose of mutants did not. Three mutants induced demyelinating disease in the central nervous system (CNS). The pathology of the demyelinating disease caused by one mutant, designated 342, was studied in detail. Pathological changes, starting 3 days post-inoculation (p.i.), were characterized by inflammation and demyelination in the CNS. Antibody responses directed against all virus-specific structural proteins were present at 7 days p.i. No virus particles were observed by electron microscopy at 14 days p.i. However, macrophages and lymphocytes were abundant in the areas of demyelination. The growth kinetics of wild-type virus, -342 and a revertant of -342 were compared. Wild-type virus and the revertant replicated rapidly in the brain and spread to the liver causing a lethal hepatitis. -342, however, replicated to a much lesser extent within the brain and could not be detected in the blood or liver. The lesion in the genome of -342 seems, therefore, to determine the outcome of the infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-3-703
1987-03-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/3/JV0680030703.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-3-703&mimeType=html&fmt=ahah

References

  1. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. 1984; Murine hepatitis virus-4 (strain JHM) induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261–270
    [Google Scholar]
  2. Dalziel R. G., Lampert P. W., Talbot P. J., Buchmeier M. J. 1986; Site specific alteration of murine hepatitis virus type-4 (MHV-4) peplomer glycoprotein E2 results in reduced neurovirulence. Journal of Virology 59:463–471
    [Google Scholar]
  3. Dubois-Dalcq M., Doller E. H., Haspel M. v. 1982; Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures. Virology 119:317–331
    [Google Scholar]
  4. Fleming J. O., Trousdale M. D., El-Zaatari F. A. K., Stohlman S. A., Weiner L. P. 1986; Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. Journal of Virology 58:869–875
    [Google Scholar]
  5. Haspel M. V., Lampert P. W., Oldstone M. B. A. 1978; Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proceedings of the National Academv of Sciences U.S.A.: 754033–4036
    [Google Scholar]
  6. Johnson G. D., Nogueiraaraujo G. M. DE C. 1981; A simple method of reducing the fading of immunofluorescence during microscopy. Journal of Immunological Methods 43:349–350
    [Google Scholar]
  7. Kessler S. W. 1975; Rapid isolation of antigens from cells with a staphylococcal protein A-antibody absorbent: parameters of the interaction of antibody-antigen complexes with protein A. Journal of Immunology 115:1617–1624
    [Google Scholar]
  8. Knobler R. L., Haspel M. V. 1981; Mouse hepatitis virus type-4 (JHM strain)-induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease. Journal of Experimental Medicine 153:832–843
    [Google Scholar]
  9. Knobler R. L., Tunison L. A., Lampert P. w., Oldstone M. B. A. 1982; Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts 15 in BALB/c and SJL/j mice. American Journal of Pathology 109:157–168
    [Google Scholar]
  10. Koolen M. J. M., Osterhaus A.D.M.E., Van Steenis G., Horzinek M. C., Van Der Zeijst B. A. M. 1983; Temperature-sensitive mutants of mouse hepatitis virus strain A59: isolation, characterization and neuropathogenic properties. Virology 125:393–402
    [Google Scholar]
  11. Koolen M. J. M., Osterhaus A.D.M.E., Siebelink K. H. J., Horzinek M. C., Van Der Zeijst B. A. M. 1984; Monoclonal antibodies to the three classes of mouse hepatitis virus strain A59 proteins. Advances in Experimental Medical Biology 173:115–116
    [Google Scholar]
  12. Koolen M. J. M., Huygen P. L. M., Calafat J., Van Der Zeijst B. A. M. 1985; Virus-induced central positional nystagmus in mice. Acta oto-laryngologica 100:172–179
    [Google Scholar]
  13. Lavi L., Gilden D. H., Highkin M. K., Weiss S. R. 1984a; Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. Journal of Virology 51:563–566
    [Google Scholar]
  14. Lavi L., Gilden D. H., Wroblewska Z., Rorke L. B., Weiss S. R. 1984b; Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34:597–603
    [Google Scholar]
  15. Moolenbeek C. 1982; A simple method for whole-body perfusion fixation of rats and mice. Zeitschrift für Versuchstierkunde 24:131–132
    [Google Scholar]
  16. Reed L. J., Muench H. 1938; A simple method for estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  17. Rottier P. J. M., Spaan W. J. M., Horzinek M. C., Van Der Zeijst B. A. M. 1981a; Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes. Journal of Virology 38:20–26
    [Google Scholar]
  18. Rottier P. J. M., Horzinek M. C., Van Der Zeijst B. A. M. 1981b; Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. Journal of Virology 40:350–357
    [Google Scholar]
  19. Siddell S. G., Anderson R., Cavanagh D., Fujiwara K., Klenk H. D., MacNaughton M. R., Pensaert M., Stohlman S. A., Sturman L., Van Der Zeijst B. A. M. 1983; Coronaviridae. Intervirology 20:181–189
    [Google Scholar]
  20. Sorensen O., Percy D., Dales S. 1980; In vivo and in vitro models of demyelinating disease. III. JHM virus infection of rats. Archives of Neurology 37:478–484
    [Google Scholar]
  21. Sturman L. S. 1977; Characterization of corona virus. I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels. Virology 77:637–649
    [Google Scholar]
  22. Tyrrell D. A. J., Alexander D. J., Almeida J. D., Cunningham C. H., Easterday B. C., Garwes D. J., Hierholzer J. C., Kapikian A., Macnaughton M. R., Mcintosh K. 1978; Coronaviridae: second report. Intervirology 10:321–328
    [Google Scholar]
  23. Van Berlo M. F., Wolswijk G., Calafat J., Koolen M. J. M., Horzinek M. C. 1986; Restricted replication of coronavirus MHV-A59 in primary mouse brain astrocytes correlates with reduced pathogenicity. Journal of Virology 58:426–433
    [Google Scholar]
  24. Watanabe R., Wege H., Ter Meulen v. 1983; Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature; London: 305150–153
    [Google Scholar]
  25. Wege H., Siddell s. G., Ter Meulen v. 1982; The biology and pathogenesis of coronaviruses. Current Topics in Microbiology and Immunology 99:165–200
    [Google Scholar]
  26. Weiner L. p. 1973; Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Archives of Neurology 28:293–303
    [Google Scholar]
  27. Woyciechowska J. L., Trapp B. D., Patrick D. H., Shekarchi I. C., Leinikki P. O., Server J. L., Holmes K. V. 1984; Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice. Journal of Experimental Pathology 1:295–306
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-3-703
Loading
/content/journal/jgv/10.1099/0022-1317-68-3-703
Loading

Data & Media loading...

Most cited Most Cited RSS feed